Marker Therapeutics, Inc. (MRKR)

2.00 +0.19 (+10.50%) USD  |  NASDAQ  |  Jan 20, 15:06
More

Marker Therapeutics Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Viridian Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade